Plus Therapeutics’ $15 Million Private Placement

Sullivan & Worcester and Hogan Lovells US advised Plus Therapeutics, while Sichenzia Ross Ference Carmel represented D. Boral Capital on the offering.Plus Therapeutics, Inc. (Nasdaq: PSTV),…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Laura Testa

Author: Laura Testa

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here